Vimarsana
Biggest News Aggregation in the World

Specimen Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Specimen Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Specimen Daily Today - Breaking & Trending Today

Insider Buying: iSpecimen Inc. (NASDAQ:ISPC) Insider Purchases $12,960.00 in Stock - Vimarsana News

Insider Buying: iSpecimen Inc. (NASDAQ:ISPC) Insider Purchases $12,960.00 in Stock

ISpecimen Inc. (NASDAQ:ISPC – Get Free Report) insider Benjamin Bielak bought 18,000 shares of iSpecimen stock in a transaction that occurred on Thursday, September 14th. The stock was purchased at an average cost of $0.72 per share, with a total value of $12,960.00. Following the completion of the transaction, the insider now owns 84,348 shares […]

Short Interest in iSpecimen Inc. (NASDAQ:ISPC) Increases By 14.1% - Vimarsana News

Short Interest in iSpecimen Inc. (NASDAQ:ISPC) Increases By 14.1%

ISpecimen Inc. (NASDAQ:ISPC – Get Rating) saw a significant growth in short interest in April. As of April 30th, there was short interest totalling 49,300 shares, a growth of 14.1% from the April 15th total of 43,200 shares. Currently, 0.9% of the company’s stock are sold short. Based on an average trading volume of 28,300 […]

Contrasting iSpecimen (ISPC) and Its Rivals - Vimarsana News

Contrasting iSpecimen (ISPC) and Its Rivals

ISpecimen (NASDAQ:ISPC – Get Rating) is one of 41 publicly-traded companies in the “Commercial physical research” industry, but how does it contrast to its competitors? We will compare iSpecimen to related businesses based on the strength of its dividends, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation. Valuation and Earnings This table compares iSpecimen […]

Contrasting iSpecimen (ISPC) & Its Rivals - Vimarsana News

Contrasting iSpecimen (ISPC) & Its Rivals

ISpecimen (NASDAQ:ISPC – Get Rating) is one of 41 public companies in the “Commercial physical research” industry, but how does it contrast to its peers? We will compare iSpecimen to related companies based on the strength of its valuation, profitability, analyst recommendations, dividends, risk, institutional ownership and earnings. Institutional & Insider Ownership 11.6% of iSpecimen […]

Head to Head Analysis: iSpecimen (ISPC) versus The Competition - Vimarsana News

Head to Head Analysis: iSpecimen (ISPC) versus The Competition

ISpecimen (NASDAQ:ISPC – Get Rating) is one of 41 public companies in the “Commercial physical research” industry, but how does it contrast to its competitors? We will compare iSpecimen to similar businesses based on the strength of its dividends, analyst recommendations, risk, profitability, earnings, institutional ownership and valuation. Institutional & Insider Ownership 11.6% of iSpecimen […]